Reducing oral steroids with inhaled steroids: Is that all that can be achieved?

Chest

Volumn 129, Issue 5, 2006, Pages 1124-1125

  Barnes, Neil C ^a,b  

^a London Chest Hospital ^*

^b LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CICLESONIDE; CORTICOSTEROID; STEROID;

ADRENAL CORTEX; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; IMAGE QUALITY; LOW DRUG DOSE; LUNG FUNCTION TEST; PRIORITY JOURNAL; STEROID THERAPY; UNSPECIFIED SIDE EFFECT;

EID: 33646493002     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.5.1124     Document Type: Editorial

References (10)

1. Morrow-Brown H, Storey G, George WMS. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. BMJ 1971; 1:585-590
2. Smith MJ, Hodson ME. High dose Beclomethasone inhaler in the treatment of asthma. Lancet 1992; 340:1483-1487
3. Lacronique J, Renon D, Georges O, et al. High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients. Eur Respir J 1991; 4:807-812
4. Tan WC, Chan TB, Lim TK, et al. The efficacy of high dose inhaled budesonide in replacing oral corticosteroid in Asian patients with chronic asthma. Singapore Med J 1990; 31:142-146
5. Nelson HS, Bernstein IL, Find J, et al. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbohaler: a double-blind, placebo-controlled study in adults with moderate to severe chronic asthma. Pulmicort Turbohaler Study Group. Chest 1998; 113:1264-1271
6. Noonan M, Chervinsky P, Busse WW, et al. Fluticasone propionate reduced oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995; 1525:1467-1473
7. Fish JE, Karpel JP, Craig TJ, et al. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. J Allergy Clin Immunol 2000; 106:852-860
8. Dietzel K, Engelstatter R, Keller A. Ciclesonide: an on-site activated steroid. Prog Respir Res 2001; 31:91-93
9. Bateman E, Karpel J, Casale T, et al. Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma. Chest 2006; 129:1176-1187
10. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326:862-866